P3 Health Partners Inc. (NASDAQ:PIII) Sees Significant Drop in Short Interest

Key Points

• P3 Health Partners Inc. experienced a significant 29.5% drop in short interest in August, with short interest totaling 24,900 shares as of August 15th.
• The company reported a quarterly loss of ($6.23) EPS, missing the consensus estimate of ($3.29), and had revenue of $355.79 million.
• Lake Street Capital has initiated coverage on P3 Health Partners with a "buy" rating and a price target of $20.00, reflecting positive sentiment from analysts.

P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report) was the recipient of a significant drop in short interest during the month of August. As of August 15th, there was short interest totaling 24,900 shares, adropof29.5% from the July 31st total of 35,300 shares. Based on an average daily volume of 7,700 shares, the short-interest ratio is presently 3.2 days. Currently,1.4% of the company's shares are short sold. Currently,1.4% of the company's shares are short sold. Based on an average daily volume of 7,700 shares, the short-interest ratio is presently 3.2 days.

P3 Health Partners Price Performance

P3 Health Partners stock opened at $8.77 on Friday. The company's 50 day simple moving average is $7.07 and its 200-day simple moving average is $7.85. The company has a market capitalization of $63.06 million, a price-to-earnings ratio of -0.19 and a beta of 0.82. P3 Health Partners has a 1 year low of $5.80 and a 1 year high of $29.19. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.31 and a current ratio of 0.31.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last posted its quarterly earnings data on Thursday, August 14th. The company reported ($6.23) EPS for the quarter, missing the consensus estimate of ($3.29) by ($2.94). P3 Health Partners had a negative net margin of 9.99% and a negative return on equity of 183.60%. The business had revenue of $355.79 million during the quarter, compared to analysts' expectations of $356.52 million. P3 Health Partners has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that P3 Health Partners will post -0.67 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Lake Street Capital assumed coverage on shares of P3 Health Partners in a research note on Thursday, August 28th. They issued a "buy" rating and a $20.00 price target on the stock. One research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $16.25.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the business. Cresset Asset Management LLC boosted its stake in shares of P3 Health Partners by 33.3% in the first quarter. Cresset Asset Management LLC now owns 200,000 shares of the company's stock valued at $33,000 after purchasing an additional 50,000 shares during the period. Wealthedge Investment Advisors LLC purchased a new position in shares of P3 Health Partners in the fourth quarter valued at approximately $83,000. Abundance Wealth Counselors boosted its stake in shares of P3 Health Partners by 77.3% in the first quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock valued at $66,000 after purchasing an additional 174,395 shares during the period. Finally, Trinity Financial Advisors LLC boosted its stake in shares of P3 Health Partners by 22.5% in the first quarter. Trinity Financial Advisors LLC now owns 1,278,037 shares of the company's stock valued at $222,000 after purchasing an additional 234,500 shares during the period. Hedge funds and other institutional investors own 7.75% of the company's stock.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.